The story of Viagra offers a tangled case study for drug investors . Initially a blockbuster success, generating billions in income , the patent expiration has opened the difficulties of relying on a one-off product. While generic versions have considerably eroded market , questions remain about the future viability of companies heavily invested in

The legacy success of copyright’s flagship drug has undeniably shaped the healthcare landscape. However, putting money in companies heavily reliant on biosimilars and the waning patent rights surrounding this iconic medication presents a considerable degree of peril . While leading pharma firms may still profit from related products , the long-te

The glittering lights and adrenaline rush of a high-stakes casino run can be intoxicating. Gamblers often search for any edge they can get, seeking ways to boost their chances of winning. Recently, whispers have circulated about a rather unconventional "secret weapon" being used by some seasoned players: Viagra. While the drug is primarily known fo